VanEck Pharmaceutical ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PPH and other ETFs, options, and stocks.

About PPH

PPH tracks a market-cap-weighted index of 25 of the largest global pharmaceutical firms. 

Index-Tracked
MSCI ACWI NR USD
Index-TrackedMSCI ACWI NR USD
Category
Health
CategoryHealth
Number of holdings
26
Number of holdings26
Inception Date
Dec 20, 2011
Inception DateDec 20, 2011

What's in this fund

Sectors

As of December 16, 2025
Healthcare100.00%

PPH Key Statistics

AUM
1.21B
AUM1.21B
Price-Earnings ratio
19.88
Price-Earnings ratio19.88
30-Day yield
1.81
30-Day yield1.81
Average volume
423.92K
Average volume423.92K
High today
$101.79
High today$101.79
Low today
$100.96
Low today$100.96
Open price
$101.66
Open price$101.66
Volume
288.08K
Volume288.08K
52 Week high
$103.56
52 Week high$103.56
52 Week low
$77.67
52 Week low$77.67
Expense ratio
0.36
Expense ratio0.36

Stock Snapshot

VanEck Pharmaceutical ETF(PPH) stock is priced at $101.00, giving the company a market capitalization of 1.2B. It carries a P/E multiple of 19.88 and pays a dividend yield of 2.1%.

On 2025-12-17, VanEck Pharmaceutical ETF(PPH) stock moved within a range of $100.96 to $101.79. With shares now at $101.00, the stock is trading +0.0% above its intraday low and -0.8% below the session's peak.

Trading volume for VanEck Pharmaceutical ETF(PPH) stock has reached 288.08K, versus its average volume of 423.92K.

Over the past 52 weeks, VanEck Pharmaceutical ETF(PPH) stock has traded between a high of $103.56 and a low of $77.67.

Over the past 52 weeks, VanEck Pharmaceutical ETF(PPH) stock has traded between a high of $103.56 and a low of $77.67.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.